These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35326640)

  • 101. Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling.
    Mulligan EA; Tudhope SJ; Hunter JE; Clift AEG; Elliott SL; Summerfield GP; Wallis J; Pepper CJ; Durkacz B; Veuger S; Willmore E
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835430
    [TBL] [Abstract][Full Text] [Related]  

  • 102. NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma.
    Jayawant E; Pack A; Clark H; Kennedy E; Ghodke A; Jones J; Pepper C; Pepper A; Mitchell S
    Front Oncol; 2023; 13():1181660. PubMed ID: 37333821
    [TBL] [Abstract][Full Text] [Related]  

  • 103. PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target.
    Sbrana FV; Fiordi B; Bordini J; Belloni D; Barbaglio F; Russo L; Scarfò L; Ghia P; Scielzo C
    J Cell Mol Med; 2023 Feb; 27(4):576-586. PubMed ID: 36747338
    [TBL] [Abstract][Full Text] [Related]  

  • 104. NF-kB and the CLL microenvironment.
    O'Donnell A; Pepper C; Mitchell S; Pepper A
    Front Oncol; 2023; 13():1169397. PubMed ID: 37064123
    [TBL] [Abstract][Full Text] [Related]  

  • 105. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
    Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma.
    Burley TA; Kennedy E; Broad G; Boyd M; Li D; Woo T; West C; Ladikou EE; Ashworth I; Fegan C; Johnston R; Mitchell S; Mackay SP; Pepper AGS; Pepper C
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326640
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.
    Godbersen JC; Humphries LA; Danilova OV; Kebbekus PE; Brown JR; Eastman A; Danilov AV
    Clin Cancer Res; 2014 Mar; 20(6):1576-89. PubMed ID: 24634471
    [TBL] [Abstract][Full Text] [Related]  

  • 108. JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL.
    Haselager MV; Thijssen R; Bax D; Both D; De Boer F; Mackay S; Dubois J; Mellink C; Kater AP; Eldering E
    Mol Oncol; 2023 Jun; 17(6):1112-1128. PubMed ID: 36550750
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Lipopolysaccharide-induced activation of NF-κB non-canonical pathway requires BCL10 serine 138 and NIK phosphorylations.
    Bhattacharyya S; Borthakur A; Dudeja PK; Tobacman JK
    Exp Cell Res; 2010 Nov; 316(19):3317-27. PubMed ID: 20466000
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers.
    Lewis T; Corcoran DB; Thurston DE; Giles PJ; Ashelford K; Walsby EJ; Fegan CD; Pepper AGS; Miraz Rahman K; Pepper C
    Haematologica; 2021 Apr; 106(4):958-967. PubMed ID: 32381576
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL.
    Haselager M; Thijssen R; West C; Young L; Van Kampen R; Willmore E; Mackay S; Kater A; Eldering E
    Cell Death Differ; 2021 May; 28(5):1658-1668. PubMed ID: 33495554
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.
    Tsubaki M; Seki S; Takeda T; Chihara A; Arai Y; Morii Y; Imano M; Satou T; Shimomura K; Nishida S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114380
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL.
    Haselager MV; Kielbassa K; Ter Burg J; Bax DJC; Fernandes SM; Borst J; Tam C; Forconi F; Chiodin G; Brown JR; Dubois J; Kater AP; Eldering E
    Blood; 2020 Dec; 136(25):2918-2926. PubMed ID: 32603412
    [TBL] [Abstract][Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.